RxSight continues to expand access to the Light Adjustable Lens through its growing network of trained surgeons and certified practices across the United States and select international markets. The ...

Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European commercial availability of the preloaded ...

Dr. Yangzhi Zhu from the Terasaki Institute for Biomedical Innovation has published a research paper titled "Real-time intraocular pressure monitoring and responsive drug delivery in preclinical ...

With best-in-class image contrast and low-light performance, TECNIS Odyssey IOL expands the Johnson & Johnson portfolio of ...

The purpose of this study was to examine the preoperative factors and postoperative outcomes following intraocular lens (IOL) exchange for high myopia in pseudophakic children. A total of 15 eyes were ...

Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...

Consecutive patients with MA50 IOLs placed in the sulcus at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA, from 1997 to 2012 were identified. Inclusion criteria included patients ...

—There is no perfect intraocular lens, but matching a patient with the lens that best meets their needs can help reduce postoperative dissatisfaction. Reviewed by Sarju Patel, MD, MPH, MSc, Director ...

The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

These studies found that IOL implant errors were due to intraoperative errors including failure to check the lens specifications, a lack of procedure for verification of the correct lens, confusion of ...